Neither severe apnea resulting in desaturation nor bradycardia due to apnea during the perioperative course was observed. observed. Each vision of the infants was treated with a separate process. The average recovery time was 3.9 0.9?min in all infants. During recovery, three patients experienced sinus tachycardia and one patient experienced sinus bradycardia. Only two babies experienced apnea attacks AG-120 (Ivosidenib) which were treated with mask ventilation. No coughing or vomiting was observed during feeding after two hours of anesthetic recovery. Comparison of induction, recovery time, and anesthesia duration during AG-120 (Ivosidenib) the first and second IVB administrations showed no significant differences (Table 2). Table 2 Comparison of induction time, recovery time, and anesthesia duration during the first and the second IVB administrations. thead th align=”left” rowspan=”1″ colspan=”1″ ? /th th align=”center” rowspan=”1″ colspan=”1″ First IVB /th th align=”center” rowspan=”1″ colspan=”1″ Second IVB /th th align=”center” rowspan=”1″ colspan=”1″ em P /em /th /thead Anesthesia induction time (min)2.6 0.72.5 0.8NSRecovery time (min)3.9 0.93.8 1.1NSAnesthesia period (min)10.2 1.79.9 1.9NS Open in a separate windows IVB: Intra vitreal bevacizumab, NS: AG-120 (Ivosidenib) not significant. 4. Conversation In the present study, sevoflurane mask anesthesia was performed efficiently, which facilitated the injection of intravitreal bevacizumab in patients with ROP. Endotracheal intubation was not needed in any of the infants. There was no respiratory depressive disorder or coughing during postanesthetic recovery. Bevacizumab, which is an antivascular endothelial growth factor (VEGF) antibody, is used in the treatment of ocular neovascular disorders including ROP [8]. Although anti-VEGF treatments in ROP are offlabel, it allows vascularization of the avascular retina. Relatively short procedure time with milder stress is an advantage of intravitreal bevacizumab injection compared to LPC. The appropriate anesthetic management for anti-VEGF therapy in patients with ROP is one of the issues that was not well defined. Short anesthesia induction time, stability and controllability of anesthesia during examination, quick recovery from anesthesia, and no residual anesthesia before discharge should be the main properties of a good anesthesia. As is known, sevoflurane is one of the best inhalation anesthetic that does not have any irritation in the respiratory tract, and it has small AG-120 (Ivosidenib) distribution coefficient, short induction and recovery occasions due its low blood gas partition coefficient, short equilibrium time, and quick induction making it a good choice for day surgery [9]. Selecting sevoflurane as a mask anesthetic agent provides fast depth of anesthesia and fast recovery without any prolonged effect. To the best of our knowledge, this is the first study conducted on IVB via sevoflurane mask anesthesia in ROP patients. IVB treatment in ROP is usually nerve-racking and painful to the neonate. This is partly because of the speculum used to keep the eyelids open and the intensity of the Rabbit polyclonal to PPP1R10 ophthalmoscope light [10]. Intravitreal injections may cause a short-term transient rise in intraocular pressure, which may result trigemino-vagal reflex [11]. Although topical anesthetic pretreatment can reduce the pain response [12] and general anesthesia is not necessary in all patients, topical anesthesia has some disadvantages such as stabilization of the eyeball during intravitreal injection. Because of the IVB injection under topical anesthesia in infants, inadvertent localization and possibility of lens damage may lead to complications. Immobility of the eye is very important during IVB since it has the potential complication of lens trauma [13]. Maneuvers that were utilized for vision immobility may induce stress in infants, and even examination of the eye under topical anesthesia was reported as an uncomfortable process [14]. Anesthesia should provide ideal surgical situation for the doctor beside blockage of pain perception. Sevoflurane mask anesthesia was safely and effectively used in fundus examination of preterm infants [15]. We suggested that sevoflurane AG-120 (Ivosidenib) mask anesthesia might be a safe and simple method in IVB treatment of premature babies with ROP. The sevoflurane mask anesthesia has potential complications of general anesthesia such as laryngospasm, bronchospasm, and aspiration. Also the anesthetic management takes much time and has a recovery period. These factors may cause increasing burden of anesthetic resources. Although.